Prescription Drug User Fee Rates for Fiscal Year 2024; Correction

---
identifier: "/us/fr/2023-16575"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Prescription Drug User Fee Rates for Fiscal Year 2024; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2023-16575"
section_name: "Prescription Drug User Fee Rates for Fiscal Year 2024; Correction"
positive_law: false
currency: "2023-08-03"
last_updated: "2023-08-03"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2023-16575"
document_type: "notice"
publication_date: "2023-08-03"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "88 FR 51330"
fr_volume: 88
docket_ids:
  - "Docket No. FDA-2023-N-2850"
fr_action: "Notice; correction."
---


#  Prescription Drug User Fee Rates for Fiscal Year 2024; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration is correcting a notice entitled “Prescription Drug User Fee Rates for Fiscal Year 2024” that appeared in the *Federal Register* of July 28, 2023. The document announced the rates for prescription drug user fees for fiscal year 2024. The document was published with an incorrect value in a table. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Lisa Granger, Office of Policy, Legislation, and International Affairs, Food and Drug Administration, 301-796-9115, *[email protected].*

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of July 28, 2023 (88 FR 48881), in FR Doc. 2023-15911, the following correction is made:

On page 48883, in section II.C., table 4, “CDER Actual FY 2022 Workload Volumes and Predicted FY 2024 Workload Volumes,” in the third column (“FY 2024 predictions”), fourth row (“NDA/BLA Original”), “1,136” is corrected to read “136.”

Dated: July 31, 2023.

Lauren K. Roth,

Associate Commissioner for Policy.